Technical feasibility and safety of a new, implantable reflux control system to prevent gastroesophageal reflux in patients with stents placed through the lower esophageal sphincter (with video)
Background When an esophageal stent is placed through the lower esophageal sphincter (LES), gastroesophageal reflux symptoms may persist despite high-dose proton pump inhibitor therapy. A recently developed, short segment, uncovered nitinol stent with a tricuspid-like valve can be placed inside a pr...
Gespeichert in:
| Veröffentlicht in: | Gastrointestinal endoscopy 2012, Vol.75 (1), p.174-178 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 178 |
|---|---|
| container_issue | 1 |
| container_start_page | 174 |
| container_title | Gastrointestinal endoscopy |
| container_volume | 75 |
| creator | Hirdes, Meike M., MD Vleggaar, Frank P., MD, PhD Laasch, Hans-Ulrich, MD, PhD Siersema, Peter D., MD, PhD, FASGE |
| description | Background When an esophageal stent is placed through the lower esophageal sphincter (LES), gastroesophageal reflux symptoms may persist despite high-dose proton pump inhibitor therapy. A recently developed, short segment, uncovered nitinol stent with a tricuspid-like valve can be placed inside a previously placed esophageal stent. Objective To evaluate the technical feasibility and safety of a reflux control system (RCS) in distally placed esophageal stents. Design A prospective case series. Setting Two tertiary-care referral centers. Patients This study involved 10 patients who had an “open” stent placed through the LES and 1 patient with severe bile reflux after esophagojejunostomy. Intervention Placement of an RCS with fluoroscopic and (in selected cases) endoscopic guidance, from April to October 2010. Main Outcome Measurements Technical success of RCS placement and complications. Results Placement of an RCS was successful on the first attempt in all patients; complete expansion to the wall of the host stent was confirmed by fluoroscopy in all cases. In 3 patients, the host stent migrated in |
| doi_str_mv | 10.1016/j.gie.2011.08.037 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_912795889</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0016510711021195</els_id><sourcerecordid>912795889</sourcerecordid><originalsourceid>FETCH-LOGICAL-c437t-7151024df8d2cdeb4b4983c9a5a3336b2020eaf2a5c17defe4a90f0e212722883</originalsourceid><addsrcrecordid>eNp9ks2O0zAUhSMEYsrAA7BB3iAGiQbbSZpYSEijEX_SSCwY1pbj3DQuaZzxdVr6ejwZN9PyIxasbNnfObLPuUnyVPBUcLF6vUnXDlLJhUh5lfKsvJcsBFflclWW6n6y4AQtC8HLs-QR4oZzXslMPEzOpBRqVYlikfy4AdsNzpqetWDQ1a538cDM0DA0LdDWt8ywAfavmNuOvRmiqXtgAdp--s6sH2LwPcMDRtiy6NkYYAdDZGuDdAPox86sgexPCjew0URHCLK9ix0j4bwnawsNi13w07qjFVjv9xDYXxY4dm6wkQ4v7qQ714B_-Th50Joe4clpPU--vn93c_Vxef35w6ery-ulzbMyLktBSci8aatG2gbqvM5VlVllCpNl2aqWXHIwrTSFFWUDLeRG8ZaDFLKUsqqy8-TF0XcM_nYCjHrr0EJPmYCfUCsCVVFVikhxJG3wiPRxPQa3NeGgBddzc3qjqTk9N6d5pak50jw7uU_1Fprfil9VEfD8BBikutpgBuvwD1cUsszUbPTmyAFlsXMQNFqKm8J1AWzUjXf_fcbbf9S2d3fz8Q0OgBs_hYFC1kKj1Fx_mUdsnjBB2QqhiuwnsfjQHg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>912795889</pqid></control><display><type>article</type><title>Technical feasibility and safety of a new, implantable reflux control system to prevent gastroesophageal reflux in patients with stents placed through the lower esophageal sphincter (with video)</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Hirdes, Meike M., MD ; Vleggaar, Frank P., MD, PhD ; Laasch, Hans-Ulrich, MD, PhD ; Siersema, Peter D., MD, PhD, FASGE</creator><creatorcontrib>Hirdes, Meike M., MD ; Vleggaar, Frank P., MD, PhD ; Laasch, Hans-Ulrich, MD, PhD ; Siersema, Peter D., MD, PhD, FASGE</creatorcontrib><description>Background When an esophageal stent is placed through the lower esophageal sphincter (LES), gastroesophageal reflux symptoms may persist despite high-dose proton pump inhibitor therapy. A recently developed, short segment, uncovered nitinol stent with a tricuspid-like valve can be placed inside a previously placed esophageal stent. Objective To evaluate the technical feasibility and safety of a reflux control system (RCS) in distally placed esophageal stents. Design A prospective case series. Setting Two tertiary-care referral centers. Patients This study involved 10 patients who had an “open” stent placed through the LES and 1 patient with severe bile reflux after esophagojejunostomy. Intervention Placement of an RCS with fluoroscopic and (in selected cases) endoscopic guidance, from April to October 2010. Main Outcome Measurements Technical success of RCS placement and complications. Results Placement of an RCS was successful on the first attempt in all patients; complete expansion to the wall of the host stent was confirmed by fluoroscopy in all cases. In 3 patients, the host stent migrated in <1 month with the RCS still inside. In 8 patients, the RCS was in place for a median of 134 days (range 33-225 days). Three patients died because of malignant disease progression. Eight RCSs were removed endoscopically, together with the host stent without complications. RCS migration did not occur. Limitations Small number of patients, nonrandomized design, lack of pH measurements. Conclusion Placement of an RCS in a host stent is technically feasible and safe. An RCS can be considered in symptomatic patients with open esophageal stents to prevent gastroesophageal reflux.</description><identifier>ISSN: 0016-5107</identifier><identifier>EISSN: 1097-6779</identifier><identifier>DOI: 10.1016/j.gie.2011.08.037</identifier><identifier>PMID: 22196815</identifier><identifier>CODEN: GAENBQ</identifier><language>eng</language><publisher>Maryland heights, MO: Mosby, Inc</publisher><subject>Aged ; Aged, 80 and over ; Biological and medical sciences ; Digestive system. Abdomen ; Endoscopy ; Esophageal Sphincter, Lower ; Esophageal Stenosis - therapy ; Esophagus ; Feasibility Studies ; Female ; Gastroenterology and Hepatology ; Gastroenterology. Liver. Pancreas. Abdomen ; Gastroesophageal Reflux - drug therapy ; Gastroesophageal Reflux - prevention & control ; Humans ; Investigative techniques, diagnostic techniques (general aspects) ; Male ; Medical sciences ; Middle Aged ; Other diseases. Semiology ; Prospective Studies ; Proton Pump Inhibitors - therapeutic use ; Stents - adverse effects ; Surveys and Questionnaires ; Time Factors ; Treatment Outcome</subject><ispartof>Gastrointestinal endoscopy, 2012, Vol.75 (1), p.174-178</ispartof><rights>American Society for Gastrointestinal Endoscopy</rights><rights>2012 American Society for Gastrointestinal Endoscopy</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2012 American Society for Gastrointestinal Endoscopy. Published by Mosby, Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c437t-7151024df8d2cdeb4b4983c9a5a3336b2020eaf2a5c17defe4a90f0e212722883</citedby><cites>FETCH-LOGICAL-c437t-7151024df8d2cdeb4b4983c9a5a3336b2020eaf2a5c17defe4a90f0e212722883</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.gie.2011.08.037$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,4022,27922,27923,27924,45994</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25527397$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22196815$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hirdes, Meike M., MD</creatorcontrib><creatorcontrib>Vleggaar, Frank P., MD, PhD</creatorcontrib><creatorcontrib>Laasch, Hans-Ulrich, MD, PhD</creatorcontrib><creatorcontrib>Siersema, Peter D., MD, PhD, FASGE</creatorcontrib><title>Technical feasibility and safety of a new, implantable reflux control system to prevent gastroesophageal reflux in patients with stents placed through the lower esophageal sphincter (with video)</title><title>Gastrointestinal endoscopy</title><addtitle>Gastrointest Endosc</addtitle><description>Background When an esophageal stent is placed through the lower esophageal sphincter (LES), gastroesophageal reflux symptoms may persist despite high-dose proton pump inhibitor therapy. A recently developed, short segment, uncovered nitinol stent with a tricuspid-like valve can be placed inside a previously placed esophageal stent. Objective To evaluate the technical feasibility and safety of a reflux control system (RCS) in distally placed esophageal stents. Design A prospective case series. Setting Two tertiary-care referral centers. Patients This study involved 10 patients who had an “open” stent placed through the LES and 1 patient with severe bile reflux after esophagojejunostomy. Intervention Placement of an RCS with fluoroscopic and (in selected cases) endoscopic guidance, from April to October 2010. Main Outcome Measurements Technical success of RCS placement and complications. Results Placement of an RCS was successful on the first attempt in all patients; complete expansion to the wall of the host stent was confirmed by fluoroscopy in all cases. In 3 patients, the host stent migrated in <1 month with the RCS still inside. In 8 patients, the RCS was in place for a median of 134 days (range 33-225 days). Three patients died because of malignant disease progression. Eight RCSs were removed endoscopically, together with the host stent without complications. RCS migration did not occur. Limitations Small number of patients, nonrandomized design, lack of pH measurements. Conclusion Placement of an RCS in a host stent is technically feasible and safe. An RCS can be considered in symptomatic patients with open esophageal stents to prevent gastroesophageal reflux.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Digestive system. Abdomen</subject><subject>Endoscopy</subject><subject>Esophageal Sphincter, Lower</subject><subject>Esophageal Stenosis - therapy</subject><subject>Esophagus</subject><subject>Feasibility Studies</subject><subject>Female</subject><subject>Gastroenterology and Hepatology</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Gastroesophageal Reflux - drug therapy</subject><subject>Gastroesophageal Reflux - prevention & control</subject><subject>Humans</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Other diseases. Semiology</subject><subject>Prospective Studies</subject><subject>Proton Pump Inhibitors - therapeutic use</subject><subject>Stents - adverse effects</subject><subject>Surveys and Questionnaires</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><issn>0016-5107</issn><issn>1097-6779</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9ks2O0zAUhSMEYsrAA7BB3iAGiQbbSZpYSEijEX_SSCwY1pbj3DQuaZzxdVr6ejwZN9PyIxasbNnfObLPuUnyVPBUcLF6vUnXDlLJhUh5lfKsvJcsBFflclWW6n6y4AQtC8HLs-QR4oZzXslMPEzOpBRqVYlikfy4AdsNzpqetWDQ1a538cDM0DA0LdDWt8ywAfavmNuOvRmiqXtgAdp--s6sH2LwPcMDRtiy6NkYYAdDZGuDdAPox86sgexPCjew0URHCLK9ix0j4bwnawsNi13w07qjFVjv9xDYXxY4dm6wkQ4v7qQ714B_-Th50Joe4clpPU--vn93c_Vxef35w6ery-ulzbMyLktBSci8aatG2gbqvM5VlVllCpNl2aqWXHIwrTSFFWUDLeRG8ZaDFLKUsqqy8-TF0XcM_nYCjHrr0EJPmYCfUCsCVVFVikhxJG3wiPRxPQa3NeGgBddzc3qjqTk9N6d5pak50jw7uU_1Fprfil9VEfD8BBikutpgBuvwD1cUsszUbPTmyAFlsXMQNFqKm8J1AWzUjXf_fcbbf9S2d3fz8Q0OgBs_hYFC1kKj1Fx_mUdsnjBB2QqhiuwnsfjQHg</recordid><startdate>2012</startdate><enddate>2012</enddate><creator>Hirdes, Meike M., MD</creator><creator>Vleggaar, Frank P., MD, PhD</creator><creator>Laasch, Hans-Ulrich, MD, PhD</creator><creator>Siersema, Peter D., MD, PhD, FASGE</creator><general>Mosby, Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2012</creationdate><title>Technical feasibility and safety of a new, implantable reflux control system to prevent gastroesophageal reflux in patients with stents placed through the lower esophageal sphincter (with video)</title><author>Hirdes, Meike M., MD ; Vleggaar, Frank P., MD, PhD ; Laasch, Hans-Ulrich, MD, PhD ; Siersema, Peter D., MD, PhD, FASGE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c437t-7151024df8d2cdeb4b4983c9a5a3336b2020eaf2a5c17defe4a90f0e212722883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Digestive system. Abdomen</topic><topic>Endoscopy</topic><topic>Esophageal Sphincter, Lower</topic><topic>Esophageal Stenosis - therapy</topic><topic>Esophagus</topic><topic>Feasibility Studies</topic><topic>Female</topic><topic>Gastroenterology and Hepatology</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Gastroesophageal Reflux - drug therapy</topic><topic>Gastroesophageal Reflux - prevention & control</topic><topic>Humans</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Other diseases. Semiology</topic><topic>Prospective Studies</topic><topic>Proton Pump Inhibitors - therapeutic use</topic><topic>Stents - adverse effects</topic><topic>Surveys and Questionnaires</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hirdes, Meike M., MD</creatorcontrib><creatorcontrib>Vleggaar, Frank P., MD, PhD</creatorcontrib><creatorcontrib>Laasch, Hans-Ulrich, MD, PhD</creatorcontrib><creatorcontrib>Siersema, Peter D., MD, PhD, FASGE</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Gastrointestinal endoscopy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hirdes, Meike M., MD</au><au>Vleggaar, Frank P., MD, PhD</au><au>Laasch, Hans-Ulrich, MD, PhD</au><au>Siersema, Peter D., MD, PhD, FASGE</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Technical feasibility and safety of a new, implantable reflux control system to prevent gastroesophageal reflux in patients with stents placed through the lower esophageal sphincter (with video)</atitle><jtitle>Gastrointestinal endoscopy</jtitle><addtitle>Gastrointest Endosc</addtitle><date>2012</date><risdate>2012</risdate><volume>75</volume><issue>1</issue><spage>174</spage><epage>178</epage><pages>174-178</pages><issn>0016-5107</issn><eissn>1097-6779</eissn><coden>GAENBQ</coden><abstract>Background When an esophageal stent is placed through the lower esophageal sphincter (LES), gastroesophageal reflux symptoms may persist despite high-dose proton pump inhibitor therapy. A recently developed, short segment, uncovered nitinol stent with a tricuspid-like valve can be placed inside a previously placed esophageal stent. Objective To evaluate the technical feasibility and safety of a reflux control system (RCS) in distally placed esophageal stents. Design A prospective case series. Setting Two tertiary-care referral centers. Patients This study involved 10 patients who had an “open” stent placed through the LES and 1 patient with severe bile reflux after esophagojejunostomy. Intervention Placement of an RCS with fluoroscopic and (in selected cases) endoscopic guidance, from April to October 2010. Main Outcome Measurements Technical success of RCS placement and complications. Results Placement of an RCS was successful on the first attempt in all patients; complete expansion to the wall of the host stent was confirmed by fluoroscopy in all cases. In 3 patients, the host stent migrated in <1 month with the RCS still inside. In 8 patients, the RCS was in place for a median of 134 days (range 33-225 days). Three patients died because of malignant disease progression. Eight RCSs were removed endoscopically, together with the host stent without complications. RCS migration did not occur. Limitations Small number of patients, nonrandomized design, lack of pH measurements. Conclusion Placement of an RCS in a host stent is technically feasible and safe. An RCS can be considered in symptomatic patients with open esophageal stents to prevent gastroesophageal reflux.</abstract><cop>Maryland heights, MO</cop><pub>Mosby, Inc</pub><pmid>22196815</pmid><doi>10.1016/j.gie.2011.08.037</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0016-5107 |
| ispartof | Gastrointestinal endoscopy, 2012, Vol.75 (1), p.174-178 |
| issn | 0016-5107 1097-6779 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_912795889 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | Aged Aged, 80 and over Biological and medical sciences Digestive system. Abdomen Endoscopy Esophageal Sphincter, Lower Esophageal Stenosis - therapy Esophagus Feasibility Studies Female Gastroenterology and Hepatology Gastroenterology. Liver. Pancreas. Abdomen Gastroesophageal Reflux - drug therapy Gastroesophageal Reflux - prevention & control Humans Investigative techniques, diagnostic techniques (general aspects) Male Medical sciences Middle Aged Other diseases. Semiology Prospective Studies Proton Pump Inhibitors - therapeutic use Stents - adverse effects Surveys and Questionnaires Time Factors Treatment Outcome |
| title | Technical feasibility and safety of a new, implantable reflux control system to prevent gastroesophageal reflux in patients with stents placed through the lower esophageal sphincter (with video) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T16%3A12%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Technical%20feasibility%20and%20safety%20of%20a%20new,%20implantable%20reflux%20control%20system%20to%20prevent%20gastroesophageal%20reflux%20in%20patients%20with%20stents%20placed%20through%20the%20lower%20esophageal%20sphincter%20(with%20video)&rft.jtitle=Gastrointestinal%20endoscopy&rft.au=Hirdes,%20Meike%20M.,%20MD&rft.date=2012&rft.volume=75&rft.issue=1&rft.spage=174&rft.epage=178&rft.pages=174-178&rft.issn=0016-5107&rft.eissn=1097-6779&rft.coden=GAENBQ&rft_id=info:doi/10.1016/j.gie.2011.08.037&rft_dat=%3Cproquest_cross%3E912795889%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=912795889&rft_id=info:pmid/22196815&rft_els_id=1_s2_0_S0016510711021195&rfr_iscdi=true |